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Candida albicans has become resistant to the commercially available, toxic, and expensive anti-Candida
agents that are on the market. These factors force the search for new antifungal agents from natural
resources. Cassia spectabilis had been traditionally employed by healers for many generations. The
possible mechanisms of the C. spectabilis leaf extract were determined by potassium leakage study and
the effect of the extract on the constituents of the cell wall and enzymes as well as the morphological
changes on C. albicans cells were studied along with cytotoxicity assays. The cytotoxicity result indicated
that the extract is nontoxic as was clearly substantiated by a half maximal inhibitory concentration (IC50)
value of 59.10 mg/mL. The treated cells (C. spectabilis extract) demonstrated potassium leakage of 1039
parts per million (ppm) compared to Amphotericin B (AmpB)-treated cells with a released potassium
value of 1115 ppm. The effects of the extract on the cell wall proteins illustrated that there were three
major types of variations in the expression of treated cell wall proteins: the presence of new proteins, the
absence of proteins, and the amount of expressed protein. The activities of two enzymes, a-glucosidase
and proteinase, were determined to be signiﬁcantly high, thereby not fully coinciding with the properties
of the antifungal reaction triggered by C. spectabilis. The morphology of C. albicans cells treated with the
C. spectabilis extract showed that the cells had abnormalities and were damaged or detached within the
microcolonies. Our study veriﬁes C. spectabilis leaf extract as an effective anti-C. albicans agent.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Candidiasis is a threat to public health as an opportunistic
infection that affects patients with endocrine disorders, malignant
disease, HIV/AIDS,1 and nosocomial infections.2 Candidiasis con-
tinues to be preponderant, and the yeast Candida albicans (C.P.
Robin, Saccharomycetaceae family) is the culprit in the majority of
cases. C. albicans has a staggering morphological feature thatharan).
for Food and Biomolecules,
molecules, National Taiwan Univeenables it to colonize in a variety of forms ranging from unicellular
budding yeast to true hyphae.3 A frail alteration to the host system
physiology transmutes this harmless commensal yeast into a
treacherous pathogen, resulting in malaise. Therefore, it is imper-
ative for the host defense system to alleviate the condition by
returning the yeast back to its propitious commensal state.
Candida strains are presently gaining resistance to antifungal
agents due to their contemporaneous usage, which complicates the
annihilation of the yeast. Many antifungal agents are insufﬁcient,
toxic, and expensive. The revertible nature of Candida infestation
increases the intricacy of treatment administration, and detracts
from the urgency of the development of new antifungal agents.4
Plants are valuable sources of phytochemicals. Medicinal plantsrsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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of people are accustomed to the use of these plants as they are
affordable and accessible. A quarter of all prescriptions in indus-
trialized countries are predicted to possess one or more compo-
nents derived from plants.4
The focus of this study is the plant Cassia spectabilis (syn. Senna
spectabilis) (DC) Irwin et Barn (Leguminosae family).
C. spectabilis numbers among the 600 or so species belonging to
the genus Cassia; it is widely grown as an ornamental plant in
tropical and subtropical areas. The species is extensively recognized
for its diverse biological and pharmacological properties, and has
been commonly used by traditional healers for many years5,6;
Brazilian healers, for instance, have long incorporated this plant
into treatments for ﬂu and colds, and as a laxative and purgative.6
Pharmacological reports have also identiﬁed antifungal,7 antibac-
terial,8 and antioxidant9 activities. A recent study by Torey and
Sasidharan10 enunciated the standardization of C. spectabilis leaf
methanol extract with respect to authenticity, assay methods, and
chemical constituent analysis. Torey et al11 also tested the anti-
bioﬁlm activity of C. spectabilis leaf methanol extract on a C. albicans
bioﬁlm and found that it was a good antibioﬁlm agent. Again,
Sangetha et al7 tested and reported on the toxicity of C. spectabilis
leaf methanol extract against mice. The researchers afﬁrmed that
C. spectabilis is nontoxic and recommended it as a safe natural
product for commercial utilization. However, the mechanism that
vitiates C. albicans is yet to be established even though the extract is
effective against the pathogenic yeast. This paper reports on the
mechanism of action of standardized C. spectabilis leaf extract
against a candidiasis-causing yeast, with the aim of providing a
breakthrough for prediction of the medicinal effects of the extract
so that it can be optimized for the eradication of candidiasis.12
Antimicrobial enhancement for clinical purposes has been
focused on targeting ﬁve essential components of cellular activity:
the cell wall, protein synthesis, RNA synthesis, DNA synthesis, and
intermediary metabolism.13
2. Materials and methods
2.1. Plant sampling
Fresh C. spectabilis leaves were collected from the University
Sains Malaysia (USM) campus at Penang, Malaysia in April 2009. A
single specimen was deposited in the Herbarium of the School of
Biological Sciences, USM, Pulau Pinang, Malaysia (voucher number
11033) and was authenticated by Mr Shunmugam Vellosamy. The
leaves were then separated and washed with water to remove dirt
prior to the drying process (40 C for 3 days).
2.2. Extraction
The leaf extract was prepared by macerating the dry powdered
plant material in methanol (Sigma -Aldrich, Germany) for 3 days.
Powdered leaves with an approximation of 200 g were macerated
with methanol under agitation conditions for 72 hours. The
extracted materials were then ﬁltered with No. 1 Whatman ﬁlter
paper (Whatman, Maidstone, UK) and further vaporized to dryness
using the rotary evaporator (BUCHI Rotary Evaporator R110, Buchi,
Switzerland).
2.3. Cytotoxicity assay
The cytotoxicity of the extract on Vero cells (ATCC: Manassas,
VA, USA) was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT (Sigma, USA)) assay. The Vero
cell lines were supplied by the INFORMM tissue culture laboratory.The cell lines were grown as a monolayer culture in Roswell Park
Memorial Institute (RPMI-1640) medium (Gibco, Invitrogen, UK),
supplemented with 10% fetal bovine serum (FBS, Gibco, Invitrogen,
UK), 100 units/mL penicillin (Serva Co, Germany), 100 mg/mL
streptomycin (Merck Co, Germany), and 1 g NaHCO3. The cultures
were maintained at 37 C in humidiﬁed 5% CO2 conditions. The leaf
extract of C. spectabiliswas tested for in vitro cytotoxicity using Vero
cells by the MTT assay as described by Mosmann14 with some
modiﬁcations.15 Brieﬂy, 100 mL of media (RPMI-1640) was added to
the control wells of the 96-well microtiter plate. Then,100 mL of the
C. spectabilismethanol extract (200,100, 50, 25,12.5, 6.25, 3.13,1.56,
and 0.78 mg/mL) was added into the respective treatment wells. The
ﬁnal volume for each well was 100 mL. The cultured Vero cells were
harvested by trypsinization and pooled in a 50mL vial. Then,100 mL
of the cell extract was plated into each well (1 105 cells per well)
and the microtiter plate was incubated at 37 C in a humidiﬁed 5%
CO2 incubator for 24 hours. After the incubation period, MTT (20 mL
of 5 mg/mL) was added into each well and the cells were incubated
for 4 hours at 37 C until a purple precipitate was clearly visible
under a microscope. Then, the medium together with the MTT
(190 mL) was aspirated from the wells, dimethyl sulfoxide (DMSO;
100 mL) was added, and the plates were shaken for 5 minutes.
(DMSO was added to dissolve the formazan crystals that had
formed.) The absorbance for each well was measured at 540 nm
using a microtiter plate reader (Sunrise Tecan). The percentage cell
viability (CV) was calculated using the following formula:
CV (%) ¼ Average absorbance of drug wells/Average absorbance of
control wells  100
A doseeresponse curve was plotted and the half maximal inhib-
itory concentration (IC50) value was obtained with Probit Analysis
using SPSS version 16.0 software (SPSS Inc., Chicago, IL, USA).
2.4. Determination of the minimal inhibitory concentration
An 18-hour culture of C. albicans was diluted with a sterile
physiologic saline solution [PS; 0.85% (w/v) sodium chloride] with
reference to the 0.5 McFarland standard to achieve inoculums of
approximately 108 colony forming units (CFU)/mL. A serial dilution
was carried out to give ﬁnal concentrations between 1.563 mg/mL
and 200.00 mg/mL of crude extract of C. spectabilis. The tubes were
inoculated with 500 mL yeast suspension per mL Sabouraud
dextrose broth (SDB) (Oxoid, Basingstoke, UK), homogenized, and
incubated at 37 C. After incubation, 20 mL was withdrawn from
each tube, inoculated on SDA agar plates, and incubated at 37 C for
24 hours. The minimal inhibitory concentration (MIC) value was
determined as the lowest concentration of the crude extract in the
broth medium that inhibited a visible growth of the test
microorganism.10
2.5. Potassium leakage
Ion leakage kinetics was performed according to a previously
reported method.16 Brieﬂy, C. albicans was suspended in yeast ni-
trogen base (YNB) to achieve a ﬁnal concentration of 5  106 cells/
mL. The MIC concentration (6.25 mg/mL) of the C. spectabilis leaf
extract was added to the test tubes. Amphotericin B (AmpB; 10 mg/
mL) was the positive control, and methanol was used as the
negative control. Samples of 10 mL were retrieved for ion con-
centration determination immediately after adding the extract and
AmpB at 15-minute intervals for a period of 60 minutes. Equivalent
samples were taken from the negative control at the same time of
incubation. After centrifugation, the supernatant was used for ion
determination with a Perkin Elmer 403 atomic absorbance
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determined after calibration with KCl at 383 nm. The evaluation
was performed in triplicate.
2.6. Isolation of cell wall proteins
Fresh C. albicans isolates were ﬁrst cultured in yeast peptone
dextrose (YPD) broth for 14 hours at 37 C. The culture was divided
into twouponwhichone samplewas treatedwith 6.25mg/mLof the
C. spectabilis leaf extract for 10 hours at 37 C while methanol was
added to the other sample and used as an untreated negative con-
trol. The isolation of cell walls from C. albicans was performed
following the procedures by Pitarch et al.17 The cells were harvested
bycentrifugation at 4500 g for 5minutes. The cell pelletwaswashed
in ice-cold sterile distilled water and resuspended in ice-cold lysis
buffer (10 mM TriseHCl, pH 7.4, 1 mM phenylmethylsulfonyl ﬂuo-
ride, PMSF). Then, 0.5 mm of chilled, acid-washed glass beads
(Sigma, St. Louis, MO, USA) were added and the cells were me-
chanically disrupted. After centrifugation, the pellet was succes-
sively washed with cold water and gradual concentrations of NaCl
(5%, 2%, and 1%) in 1 mM PMSF. Sodium dodecyl sulfate/dithio-
threitol (SDS/DTT)-extractable proteins were extracted by boiling
the puriﬁed cell walls in SDS extraction buffer (50mM TriseHCl, pH
8.0, 0.1 M EDTA, 2% SDS, 10 mM DTT) at 100 C for 10 minutes. The
sample was centrifuged for 10 minutes at 1000 g and the superna-
tant was precipitated using trichloroacetic acid (TCA). The pellet
obtained from the above was used for the subsequent extraction
usingmild alkali conditions. The cell walls were resuspended in ice-
cold wash buffer (0.1 M sodium acetate, pH 5.5, 1 mM PMSF),
centrifuged for 10 minutes at 1000 g, and the supernatant was
discarded. This stepwas repeated sixmore times. The cellwallswere
then resuspended in ice-cold extraction solution (30 mM NaOH,
1 mM PMSF) and the cell wall suspension was incubated at 4 C for
17 hours. The suspension was centrifuged for 10 minutes at 1000 g
and the supernatant was collected and precipitated using TCA. TCA
(20% ﬁnal concentration) was added to the supernatant obtained
from the procedures above and the samples were incubated for
30 minutes on ice. The suspensionwas then centrifuged at 10,000 g
for 15 minutes and the supernatant was discarded. The proteins
were visible as awhite, stringymass. The protein pellet waswashed
twice with cold acetone to remove residual TCA and the pellet was
air-dried and stored at 80 C until further use.
2.7. SDS-polyacrylamide gel electrophoresis
Samples were taken up in SDS loading solution and 20 mL was
loaded onto 10e20% BioRad Criterion gel. Precision Plus protein
molecular mass markers were use as standards. The gel was run for
160 minutes at a voltage of 140 V. The gel was stained using the
colloidal Coomassie Brilliant Blue G-250. All SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) dyes, reagents, and equipment
were from Bio-Rad (Hercules, CA, USA).
2.8. a-Glucosidase activity
The a-glucosidase activity wasmeasured using p-nitrophenyl-a-
D-glucopyranoside (Sigma, Germany) as a substrate based on a
previously described method with some modiﬁcations.18 Intact or-
ganisms of 4106 cells in 1.1 mL PBS were incubated with 6.25 mg/
mL of the C. spectabilis extract and 5mM substrate in 1.0 mL of 0.1M
phosphate-citrate buffer (pH 6.0) for 2 hours at 37 C. A negative
control containingmethanol was used for comparison. The reaction
was terminated by the addition of 2mL of ice-cold 0.1MNa2CO3. The
p-nitrophenol thatwas released in the supernatantwas then read at
an optical density (OD) of 405 nm. The a-glucosidase activity wascalculated by using a standard curve of p-nitrophenol. The testing
was done in triplicate. The preparation of the standard curve was
done by preparing p-nitrophenol with concentrations of 140, 70, 35,
17.5, 8.75, and 0 mM in test tubes. The tubes were vortexed and the
absorbance was read at OD 405 nm. A standard curve was plotted
using the p-nitrophenol standard and the amount of a-glucosidase
released was calculated using the following formula:
a glucosidase activity in the sampleðmU=mLÞ
¼
1
Slope OD405  Total volume
Time Sample volume2.9. Proteinase activity
The culture conditions and treatment with plant extract were
carried out according to a previously reported method.19 YYG
medium (15 mL) (1.17% yeast carbon base, 0.01% yeast extract,
0.27% glucose) containing 6.25 mg/mL of the C. spectabilis leaf
extract was inoculated with 106 CFU of C. albicans and incubated
at 37 C for 48 hours while shaking at 60 rpm. Methanol was used
as a negative control. The proteinase assay was undertaken using a
modiﬁcation of the previous method20 by adding 0.2 mL of the
supernatant to 2 mL of 0.1 M citrate buffer (pH 3.2) containing
0.2% bovine serum albumin (BSA) and incubating at 37 C for
2 hours. The reaction was stopped using 5% ice-cold trichloroacetic
acid. The mixture was centrifuged at 5000 rpm for 30 minutes and
the supernatant was read at an absorbance of 750 nm on a
spectrophotometer.2.10. Effect on the morphology of C. albicans
The C. albicans cells were treated with 6.25 mg/mL10 (the MIC21
obtained from our previous study) of the C. spectabilis leaf extract
for 36 hours. After treatment with C. spectabilis extract, scanning
electron microscopy (SEM) observation was carried out on
C. albicans bioﬁlm. The plate containing 25 mL potato dextrose
agar medium was seeded with 1 mL of the C. albicans suspension
containing 10 cells per mL from a 24-hour-old culture. The extract
(1 mL), at the concentration of 6.25 mg/mL, was then dropped
onto the inoculated agar and was further incubated for another
36 hours at 37 C. A 1.0% DMSO-treated culture was used as a
control. Segments (5e10 mm) were cut from cultures growing on
potato dextrose plates at 36 hours for SEM examination. The
specimen was placed on the double-stick adhesive tabs on a
planchette. Subsequently, the planchette was placed on a Petri
plate. In a fume hood, a vial cap containing 2% osmium tetroxide in
water was placed in an unoccupied quadrant of the plate. After
being covered, the plate was sealed with paraﬁlm, and vapor ﬁx-
ation of the sample proceeded for 1 hour. Once the sample was
vapor-ﬁxed, the planchette was plunged into slush nitrogen
(210 C) and transferred on to the “peltier-cooled” stage of the
freeze dryer (Emitech K750), and freeze drying of the specimen
proceeded for 10 hours. Finally, the freeze-dried specimen was
sputter-coated with 5e10 nm of gold before viewing in the SEM
(FESEM LEO Supra 50 VP; Carl Zeiss, Germany) operating at 5 kV at
5.00 k  of magniﬁcation.2.11. Statistical analysis
All datawere analyzed and comparedusing a Student t test in SPSS
software. A p value <0.05 was considered statistically signiﬁcant.
Fig. 2. Leakage of potassium found in Candida albicans cells treated with Cassia
spectabilis leaf extract, p < 0.05.
A. Torey et al. / Journal of Traditional and Complementary Medicine 6 (2016) 97e1041003. Results
3.1. Cytotoxicity assay
The IC50 value obtained from the MTT assay was 59.10 mg/mL.
Microscopic images of Vero cells at different concentrations are
displayed in Fig. 1AeC. Normal, untreated Vero cells are presented
in Fig. 1Adthe cells appear as a monolayer of elongated cells with
nuclei positioned in the middle and attached to the surface of the
microtiter plate. Fig.1B shows C. spectabilis-treated (50 mg/mL) Vero
cellsdthis concentration correlates with the IC50 concentration
acquired earlier, hence elucidating the damage in 50% of the Vero
cells, which is depicted with shriveled and detached characteristics
on the microtiter plate surface. By contrast, Fig. 1C shows Vero cells
treated with 200 mg/mL of the C. spectabilis leaf extract; no viable
cells are observed here.
3.2. Determination of the MIC
The broth dilution method recorded the MIC value of 6.25 mg/
mL against the C. albicans test strain. Therefore, this concentration
was used for further testing.
3.3. Potassium leakage
Potassium (Kþ) ion leakage was estimated using atomic ab-
sorption spectroscopy (AAS) and the resulting patterns are pre-
sented in Fig. 2. It was found that the methanol extract ofFig. 1. Microscopic images of Vero cells. (A) Untreated Vero cells. (B) Cells treated with
Cassia spectabilis leaf extract at the concentration 50 mg/mL. (C) Cells treated with
C. spectabilis leaf extract at the concentration 200 mg/mL.C. spectabilis was effective in leakage of Kþ ions by releasing
1039 ppmwhereas AmpB (positive control) released comparatively
higher ions than the extract (1115 ppm). The Kþ ions were instantly
detected within the culture supernatant upon extract treatment
initiation, to which progressive increments were observed peaking
at 30 minutes of exposure, after which they declined. By contrast,
C. albicans cells treated with AmpB managed to achieve their peak
after 15 minutes. Untreated C. albicans cells served as a negative
control whereby the cells had small traces of Kþ ions in the culture
supernatant. This result illustrates that Kþ ions are leaked from the
cells within 60 minutes of interaction between the organism and
the extract.3.4. Effect on C. albicans cell wall proteins
The result obtained from the SDS-PAGE is shown in Fig. 3. There
were two extraction methods: SDS/DTT and NaOH extractions. On
extraction with SDS/DTT, the C. albicans cell walls expressed two
new proteins (red arrows). One of these proteins was measured to
be in the range of 37e50 kDa inmolecular weight whereas the other
protein was between 20 kDa and 25 kDa in molecular weight. As for
the extraction using NaOH, threemajor proteins were discovered to
be absent in the cell walls of treated C. albicans compared to the
untreated ones (white arrows). When compared to the untreated
sample, two of these absent proteins were identiﬁed to be within
the range 37e50 kDa in molecular weight while the ﬁnal one was
estimated to be in the range 50e75 kDa in molecular weight. A
thinner and fainter protein band in the treated sample (black ar-
row) indicated lower protein expressiondthis was observed with
both SDS/DDT and NaOH extraction methods. The low-expressed
proteins were noted to be about 10 kDa in the SDS/DTT extraction
sample and around 37 kDa in the NaOH extraction sample.3.5. a-Glucosidase activity
Fig. 4 depicts the a-glucosidase activity of the C. albicans cells
treated with 6.25 mg/mL of the leaf extract. The activity of the
treated cells was compared to those of an untreated control. It was
found that the cells treated with the extract possessed a signiﬁ-
cantly higher a-glucosidase activity compared to the untreated
control. The activity of the treated cells was 0.432 ± 0.003 mU/mL,
while the activity of the untreated cells was 0.048 ± 0.001 mU/mL
(p < 0.05).
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Fig. 5. Proteinase activity of Candida albicans treated with Cassia spectabilis leaf
extract.
Fig. 3. SDS-PAGE of Candida albicans cell wall proteins under the effect of the Cassia
spectabilis leaf extract. Lanes: 1, Precision Plus molecular mass markers; 2, SDS/DTT-
extracted proteins (untreated control); 3, SDS/DTT-extracted proteins (treated with
6.25 mg/mL C. spectabilis leaf extract); 4, NaOH-extracted proteins (untreated control);
5, NaOH-extracted proteins (treated with 6.25 mg/mL C. spectabilis leaf extract). Mo-
lecular mass standards are expressed on the left of the gel (in kilodaltons, kDa). White
arrows indicate the absence of that protein in the treated counterpart; black arrows
indicate less protein expression compared to the untreated counterpart; red arrows
indicate a new protein compared to the untreated counterpart. DTT ¼ dithiothreitol;
PAGE ¼ polyacrylamide gel electrophoresis; SDS ¼ sodium dodecyl sulfate.
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Fig. 5 shows the results of the proteinase activity of the
C. albicans cells. The activity of the treated cells was compared to
those of an untreated control. It was observed that the cells treated
with the C. spectabilis leaf extract (6.25 mg/mL) exhibited a signif-
icantly higher proteinase activity compared to the control. The
absorbance value (at 750 nm) of the supernatant for the treatedG
A
B
Fig. 4. a-Glucosidase activity evaluated from Candida albicans treated with Cassia
spectabilis leaf extract.cells was 0.033 ± 0.001, while the untreated cells gave an absor-
bance value of 0.025 ± 0.001 (p < 0.05).Fig. 6. Morphological changes observed on (A) untreated control Candida albicans cells
and (B) C. albicans cells treated with 6.25 mg/mL C. spectabilis leaf extract.
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The SEM photomicrographs of the untreated and C. spectabilis-
treated cells of C. albicans at 36 hours are displayed in Fig. 6. Fig. 6A
depicts the untreated C. albicans cells that were used as a negative
control; the presence of bioﬁlm that connects the cells together can
be seen along with budding cells. By contrast, the treated cells
appear to be loosened from each other indicating a deteriorated
bioﬁlm (Fig. 6B); the cells seemed to develop small ruptures on the
cell surface actuating in cell convulsion; the treated cells weremore
elongated compared to the untreated cells.
4. Discussion
In our study, a few characteristics were disclosed ascertaining
the possible patterns by which C. spectabilis leaf extract may act
upon C. albicans. Fig. 7 depicts the anticandidal mechanistic pattern
of C. spectabilis leaf extract. The activity of the extract suggests a
promising mechanism for altering cell wall and cell membrane
components, inhibiting DNA, and affecting protein synthesis and
metabolism of C. albicans. An extract possessing distinctive active
compounds is associated with multiple mechanisms of action, each
ascribable to a specialized compound or group of compounds. The
rigid cell wall of C. albicans is composed mainly of glucans and
chitins22 offering the notion that some compounds might be
responsible for the initial step of cell wall penetration, before
allowing the rest of the crude extract compounds to access further
into the cell causing more damage.
The complete procedure for discovering and developing a new
therapeutic agent is highly expensive and tedious, often stretching
over a 12-year period. Identifying the potential toxic compound is
an imperative step for early drug development. The IC50 value ob-
tained when Vero cell lines were treated with C. spectabilis extract
was 59.10 mg/mL; this valuewas considered nontoxic because it was
more than 20 mg/mL.23 A previous study conducted by Sangetha
et al7 on the same leaf extract using mice oral acute toxicity tests7
further veriﬁes the nature of C. spectabilis leaf extract as nontoxic.
Toxic effects of an antimicrobial agent should be pondered delib-
erately especially when concerning host cells. Any single substance
from a crude extract is capable of inevitably causing perturbance.24
Nevertheless, it was surprising that the toxic effect of C. spectabilis
leaf extract was exhibited on C. albicans rather than on Vero cells,
suggesting that the extract displayed selective toxicity towards
yeast cells. Although there are many commercial drugs readilyFig. 7. Mechanistic patterns displayed by Cassia spectabilis on Candida albicans.available to treat candidiasis, C. spectabilis fortuitously reveals its
competence in inhibiting C. albicans growth (Fig. 1B) as well as
being less toxic to Vero cells (Fig. 1A). It can be corroborated that
C. spectabilis leaf extract is a potent in vitro anticandidal agent. Cell
culture can be used to screen for toxicity both by estimation of the
basal functions of the cell (i.e., those processes common to all types
of cells) or by tests on specialized cell functions.25 General toxicity
tests, aimed mainly at detection of the biological activity of test
substances, can be carried out on many cell types (e.g., ﬁbroblasts,
HeLa cells, and hepatoma cells). A number of parameters including
vital staining, cytosolic enzyme release, cell growth, and cloning
efﬁciency are used as end-points to measure toxicity.26 Hence, in
this study Vero cells from a monkey were used for the cytotoxicity
assay.
The osmotic balance of a cell can be easily affected by the
changes in potassium ions (Kþ), and ion leakage from a cell may
result in cell lysis. These ions play crucial roles in activating
essential enzymes that function as organic catalysts mediating
prominent biochemical reactions.27 C. albicans cells treated with
C. spectabilis were evaluated for Kþ leakage and the efﬁcacy was
compared to AmpB (antifungal agent, positive control). AmpB binds
to ergosterol causing the formation of aqueous channels that in-
crease membrane permeability to univalent cations resulting in cell
death.28 A gradual leakage of Kþ ions by the treated C. albicans cells
was shown here (Fig. 2) corresponding to the time of treatment
exposure; this result was as good as the effect of the commercial
antifungal drug AmpB on Kþ leakage in C. albicans. The leaf extract
pattern coined a perception that the extract had altered the
membrane of the C. albicans intensifying its permeability to release
Kþ ions. The fungal plasma membrane is constituted predomi-
nantly by phospholipids, sphingolipids, and sterols that together
serve as a permeability barrier concurrent to the transport of small
molecules. Among other things, these components also transmit
signals and serve as a matrix for proteins with various func-
tions.29,30 Therefore, when this membrane is compromised, it will
cause an efﬂux of intracellular potassium. Cox et al31 studied the
inﬂuence of tea tree oil on C. albicans and drew the conclusion that
leakage of Kþ ions was an indication of cell membrane structure
damage. Similarly, Wei et al32 performed an analysis of Kþ leakage
to investigate plasma membrane injury in C. albicans and asserted
that the outﬂow of Kþ ions was associated with yeast cell mem-
brane permeability. This result can also be related to other anti-
fungal mechanisms such as binding of the drug to sterols to
increase permeability, inhibition of ergosterol synthesis, or even
dysfunctional membranal enzymes.33
Other methods can also be used to assess the membrane dam-
age caused by antifungal agents, for example, assessment of ATP
leakage by fungal cells was employed by Kulakovskaya et al.34 Ac-
cording to Nagarsekar et al,35 cytoplasmic membrane damage can
be evidenced by leakage of cellular Kþ ions. Hence, it is concluded
that the C. spectabilis leaf extract caused membrane damage in the
C. albicans cells.
Proteomic analysis of C. albicans cell wall proteins was per-
formed to substantiate the association of Kþ ion leakage with cell
membrane damage. The C. albicans cell wall is very signiﬁcant in
terms of biology and pathogenicity.36 The mechanical and osmotic
balance of the yeast is achieved by its cell wall, which is constructed
mainly of carbohydrates with a basic network complex of b-glu-
cans, chitin, and mannan.37e40 The yeast cell wall forms a deﬁnite
boundary in providing mechanical stability and cell tugor,40 in
addition to its role in the construction of the outer fungal structural
surface. The cell wall, being the ﬁrst point of contact when sub-
jected to the C. spectabilis leaf extract, pointedly provokes inter-
ruption in the organization or functions of the cell wall
components. These alterations within the cell wall organization are
A. Torey et al. / Journal of Traditional and Complementary Medicine 6 (2016) 97e104 103inspected at the molecular level through its cell wall protein
expression. Considering the fact that proteins are the ultimate gene
products and representatives of various physiological and patho-
logical processes of the living cell, the ﬁeld of proteomics has made
allowances for the inﬂuence of different conditions on the
expression of proteins.41,42 For this reason, the cell wall protein
expression was investigated to ratify the alteration involving the
cell wall constituents caused by the C. spectabilis leaf extract.
Different biochemical approaches have been used to identify pro-
teins that are randomly scattered along the cell wall. The non-
covalently attached proteins are extracted using SDS/DDT while
covalently bound proteins are extracted by NaOH treatment (mild
alkali treatment).40 The presence of new proteins can be proposed
as the action of C. spectabilis leaf extract in disintegrating cell wall
moieties into smaller peptides. Low protein expression levels may
result from the possible disintegration of proteins into smaller
peptides making them imperceptible between the bounds of the
standard molecular mass weights. Mahmoud and Aly43 reported
the differences in cell wall protein expression using SDS-PAGE; they
uncovered an increase in phosphopeptidomannan of molecular
weights 45 kDa, 25 kDa, and 15 kDa when C. albicans was treated
with a polymer. Other conditions are also capable of modifying the
composition of the cell wall. For example, an elevated level of
Candida Pir2-related protein was found to be a reason for vulner-
ability of C. albicans.39 Then again, the featured changes in cell wall
proteins solidly attest the changes in protein expression.
C. albicans is well advanced in secreting an assortment of hy-
drolytic enzymes such as a-glucosidase and proteinase. The yeast
secretes these enzymes as part of its mechanism to invade and
proliferate. It causes destruction to the host cells when it degrades
healthy tissues to supply its nutrient needs.44 The enzymes a-
glucosidase and proteinase are culpable in the virulence of
C. albicans and were found to be signiﬁcantly higher in treated
C. albicans cells in contrast with untreated control cells. Fekete
Forgacs et al45 examined the possibility of a-glucosidase being a
virulence factor. The enzyme activity was compared between a
ﬂuconazole-resistant C. albicans strain and a ﬂuconazole-sensitive
strain and they found that a-glucosidase plays an insigniﬁcant
role in the virulence of C. albicans. There was no correlation be-
tween a-glucosidase and proteinase.
The proteinase activity of C. albicans cells is divulged generally
as a repercussion of virulence. Some time ago, it was reported that
a C. albicans culture ﬁltrate manifested many types of hydrolytic
enzymes including proteinases, phospholipases, acid phospha-
tases, chitinases, esterases, and glucoamylases.38 Cutler46 showed
that the release of proteinase was associated with cell death. Given
that C. spectabilis had earlier demonstrated antibioﬁlm activities
towards C. albicans, the feeble yeast cells of Cutler’s study can be
used to rationalize the high proteinase activities. Cassone et al47
discovered the presence of proteinase in pathogenic strains iso-
lated from cases of candidal vaginitis and those of carriers.
Schreiber et al48 did not ﬁnd a correlation between the volume of
proteinase generated by various clinical and normal C. albicans
strains with the invasion level of the strains. More to the point,
another study found similar production of proteinase in a low-
virulence mutant of C. albicans and virulent parent strains.49 The
increase in proteinase activity alone is not sufﬁcient to be
considered a virulence factor as Dubois et al50 revealed that a
systemic infection-causing mutant C. albicans in mice transformed
from being virulent to avirulent when proteinase was overex-
pressed. The authors believe that the overexpressed proteinase
might have resulted from compromised yeast cell walls, otherwise
the mice host immune system would not been able to eliminate
these C. albicans unless they were susceptible. In general terms,
the high a-glucosidase and proteolytic activity of C. albicans is anindication of altered metabolism caused by the C. spectabilis leaf
extract.
C. albicans cells were exposed to the C. spectabilis leaf extract for
36 hours, and the morphological alterations were viewed through
SEM along with other untreated cells. Few structural differences
were noted in the treated cells. The exterior outline of the cells
seemed to shrivel and elongate. The cells also appeared to be de-
tached from each other elucidating certain disturbance in the bio-
ﬁlm formation. One of the major contributors to candidiasis
occurring at an alarming rate is the propensity of C. albicans for
bioﬁlm formation. The bioﬁlm forms when single cells attach to a
surface and grow into microcolonies, followed by blended pro-
duction of a complex three-dimensional (3D) structure held by
hyphae and exopolymer matrix.51 The bioﬁlm acts as a barrier,
preventing penetration by immune system components or even
antifungal agents.51e53 Critically, SEM revealed the after-effect of
the C. spectabilis leaf extract on C. albicans bioﬁlm construction. The
destruction of the bioﬁlm that occurs in treated cells facilitates the
host immune system to eliminate the pathogen, thereby eradi-
cating candidiasis.
5. Conclusion
Taken together, our ﬁndings demonstrated that C. spectabilis leaf
extract is nontoxic to Vero cells and is effective against C. albicans
bioﬁlms. Future studies will be necessary to identify the protein
changes that occur within the cell wall during treatment, as well as
the isolation and the characterization of active compound(s) with
antibioﬁlm activity. In conclusion, C. spectabilis leaf extract has
strong anticandidal activity with various mechanisms of action.
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